347 related articles for article (PubMed ID: 25239263)
21. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
[TBL] [Abstract][Full Text] [Related]
22. Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes?
Padron E
Hematology Am Soc Hematol Educ Program; 2015; 2015():349-54. PubMed ID: 26637742
[TBL] [Abstract][Full Text] [Related]
23. Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.
Hebeda KM; Tzankov A; Boudova L; Saft L; Hasserjian RP; de Boer M; Fend F; Orazi A; Leguit R
Pathobiology; 2019; 86(1):62-75. PubMed ID: 29982244
[TBL] [Abstract][Full Text] [Related]
24. Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children.
Gilad O; Dgany O; Noy-Lotan S; Krasnov T; Yacobovich J; Rabinowicz R; Goldberg T; Kuperman AA; Abu-Quider A; Miskin H; Kapelushnik N; Mandel-Shorer N; Shimony S; Harlev D; Ben-Ami T; Adam E; Levin C; Aviner S; Elhasid R; Berger-Achituv S; Chaitman-Yerushalmi L; Kodman Y; Oniashvilli N; Hameiri-Grosman M; Izraeli S; Tamary H; Steinberg-Shemer O
Haematologica; 2022 Sep; 107(9):2081-2095. PubMed ID: 35295078
[TBL] [Abstract][Full Text] [Related]
25. Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
Fernandez-Mercado M; Burns A; Pellagatti A; Giagounidis A; Germing U; Agirre X; Prosper F; Aul C; Killick S; Wainscoat JS; Schuh A; Boultwood J
Haematologica; 2013 Dec; 98(12):1856-64. PubMed ID: 23831921
[TBL] [Abstract][Full Text] [Related]
26. Genomic landscape of CD34+ hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers.
Xu L; Gu ZH; Li Y; Zhang JL; Chang CK; Pan CM; Shi JY; Shen Y; Chen B; Wang YY; Jiang L; Lu J; Xu X; Tan JL; Chen Y; Wang SY; Li X; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8589-94. PubMed ID: 24850867
[TBL] [Abstract][Full Text] [Related]
27. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
[TBL] [Abstract][Full Text] [Related]
29. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
Tawana K; Drazer MW; Churpek JE
Leukemia; 2018 Jul; 32(7):1482-1492. PubMed ID: 29483711
[TBL] [Abstract][Full Text] [Related]
30. Pediatric Myelodysplastic Syndromes.
Patel SS
Clin Lab Med; 2021 Sep; 41(3):517-528. PubMed ID: 34304779
[TBL] [Abstract][Full Text] [Related]
31. Aplastic anemia and clonal evolution: germ line and somatic genetics.
Shimamura A
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
[TBL] [Abstract][Full Text] [Related]
32. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
[TBL] [Abstract][Full Text] [Related]
33. Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications.
Kallen ME; Dulau-Florea A; Wang W; Calvo KR
Semin Hematol; 2019 Jan; 56(1):69-82. PubMed ID: 30573048
[TBL] [Abstract][Full Text] [Related]
34. Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.
Blombery P; Fox L; Ryland GL; Thompson ER; Lickiss J; McBean M; Yerneni S; Hughes D; Greenway A; Mechinaud F; Wood EM; Lieschke GJ; Szer J; Barbaro P; Roy J; Wight J; Lynch E; Martyn M; Gaff C; Ritchie D
Haematologica; 2021 Jan; 106(1):64-73. PubMed ID: 32054657
[TBL] [Abstract][Full Text] [Related]
35. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
[TBL] [Abstract][Full Text] [Related]
36. High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS).
Mohamedali AM; Gäken J; Ahmed M; Malik F; Smith AE; Best S; Mian S; Gaymes T; Ireland R; Kulasekararaj AG; Mufti GJ
Leukemia; 2015 Sep; 29(9):1928-38. PubMed ID: 25943179
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between clinical features and somatic gene mutations in myelodysplastic syndrome].
Hirasawa N; Sakata-Yanagimoto M; Nannya Y; Hattori K; Suehara Y; Kato T; Yokoyama Y; Kurita N; Obara N; Ogawa S; Hasegawa Y; Chiba S
Rinsho Ketsueki; 2018; 59(1):80-83. PubMed ID: 29415943
[TBL] [Abstract][Full Text] [Related]
38. [Sternal bone marrow cell morphology evaluation utility for diagnostic categorization in patients with acquired hypocellular bone marrow failure syndromes].
Chen J; Qin TJ; Qu SQ; Pan LJ; Zhang PH; Li B; Xiao ZJ; Xu ZF
Zhonghua Xue Ye Xue Za Zhi; 2022 Nov; 43(11):928-933. PubMed ID: 36709184
[No Abstract] [Full Text] [Related]
39. Clinical effect of point mutations in myelodysplastic syndromes.
Bejar R; Stevenson K; Abdel-Wahab O; Galili N; Nilsson B; Garcia-Manero G; Kantarjian H; Raza A; Levine RL; Neuberg D; Ebert BL
N Engl J Med; 2011 Jun; 364(26):2496-506. PubMed ID: 21714648
[TBL] [Abstract][Full Text] [Related]
40. Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists.
Crisà E; Boggione P; Nicolosi M; Mahmoud AM; Al Essa W; Awikeh B; Aspesi A; Andorno A; Boldorini R; Dianzani I; Gaidano G; Patriarca A
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
